Peter A. Schneider, M.D.
- Professor of Surgery
- Division of Vascular & Endovascular Surgery
Contact Information
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
peter.schneider@ucsf.edu
Education
The Johns Hopkins University School of Medicine Five-Year BA-MD Curriculum, The Johns Hopkins University, Baltimore, MD, Class of 1983
Undergraduate, University of California San Diego, La Jolla, CA, 1976-1978
Residencies
- University of California San Francisco, San Francisco, CA
- Resident in General Surgery, June, 1983 to June, 1986 and July, 1988 to June, 1989
- Chief Resident in General Surgery, July, 1989 to June, 1990
Fellowships
- Research Fellowship: Roon Center of Arteriosclerosis and Thrombosis, Department of Basic Research and Noninvasive Vascular Diagnostic Laboratory, Scripps Clinic and Research Foundation, La Jolla, CA, July, 1986 to June, 1988
- Clinical Fellowship: University of California San Francisco, San Francisco, CA, Clinical Fellow in Vascular Surgery, July, 1990 to June, 1991
Biography
Peter A. Schneider, M.D. is Professor of Surgery in the Division of Vascular & Endovascular Surgery at University of California San Francisco. Dr. Schneider received his MD from the Johns Hopkins School of Medicine and completed his general surgery residency and vascular surgery fellowship at the University of California San Francisco.
Dr. Schneider was the founding member and chief of the Division of Vascular Surgery at Kaiser Permanente in Hawaii from 1994-2018. At Kaiser, he helped to develop a Diabetic Limb Treatment Program and a surveillance program for patients with aneurysms and a registry for patients with carotid disease used for surveillance. He oversaw the development of the first endovascular operating room in the Kaiser system.
Dr. Schneider has served on numerous committees for the Society for Vascular Surgery and is the past president of Western Vascular Society where he also served on a number of its committees. He has been invited to numerous visiting professorships and has served as faculty or course director for many specialty courses. He authored "Endovascular Skills," the 4th edition, to be published in 2019, and has co-authored three other books on various aspects of vascular surgery. Dr. Schneider founded two medical device companies, served as an adviser to many others, and has been awarded numerous patents.
Dr. Schneider is a Distinguished Fellow of the Society for Vascular Surgery.
Research Overview
Dr. Schneider has served as National Principal Investigator for numerous clinical trials. Over 25 years, he has been a strong proponent of clinical research in vascular disease and has participated extensively in trial design, oversight, core lab analysis, events committees, data analysis, follow up, presentation, and publication. He has consulted on the regulatory pathway and pivotal trials for many vascular devices, has participated in numerous meetings with the FDA and has testified at FDA panel hearings. His experience includes performing procedures for several first-in-human trials.
Publications
MOST RECENT PUBLICATIONS FROM A TOTAL OF 112
- Liu IH, Wu B, Krepkiy V, El Khoury R, Ferraresi R, Reyzelman AM, Hiramoto JS, Schneider PA, Conte MS, Vartanian SM. Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal revascularization for chronic limb-threatening ischemia. J Vasc Surg. 2022 Dec; 76(6):1688-1697.e3. View in PubMed
- El Khoury R, Wu B, Kupiec-Weglinski SA, Liu IH, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Conte MS. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia. J Vasc Surg. 2022 10; 76(4):997-1005.e2. View in PubMed
- Giannopoulos S, Secemsky EA, Schneider PA, Armstrong EJ. Concomitant Drug-Coated Balloon Angioplasty With Bail-Out Use of Eluvia Drug-Eluting Stent: Is There Any Downside to a Double Dose of Paclitaxel? J Invasive Cardiol. 2022 06; 34(6):E469-E476. View in PubMed
- Kashyap VS, So KL, Schneider PA, Rathore R, Pham T, Motaganahalli RL, Massop DW, Foteh MI, Eckstein HH, Jim J, Leal Lorenzo JI, Melton JG. One-year outcomes after transcarotid artery revascularization (TCAR) in the ROADSTER 2 trial. J Vasc Surg. 2022 08; 76(2):466-473.e1. View in PubMed
- El Khoury R, Wu B, Kupiec-Weglinski SA, Dang LE, Edwards CT, Lancaster EM, Hiramoto JS, Vartanian SM, Schneider PA, Simons JP, Conte MS. Applicability of the Vascular Quality Initiative mortality prediction model for infrainguinal revascularization in a tertiary limb preservation center population. J Vasc Surg. 2022 08; 76(2):505-512.e2. View in PubMed
- View All Publications
In the News
- UCSF Division of Vascular & Endovascular Surgery - - November 09, 2022BEST-CLI is an international research study aimed at figuring out the best treatment for people with peripheral arterial disease (PAD) - also known as poor blood flow, and associated with Critical Limb Ischemia (CLI). It is Federally funded by the National Heart, Lung and Blood Institute at the National Institutes of Health. As of November 2022, BEST-CLI enrollment ended in October of 2019, and completed a minimum of 24 months' follow-up for all patients in October of 2021. The primary [...]